West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products across the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; components for syringes and cartridges, which include custom solutions tailored for injectable drug applications, alongside administration systems that improve the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies. Additionally, this segment provides films, coatings, washing, vision inspection, and sterilization processes, enhancing the quality of packaging components. Drug containment solutions, such as Crystal Zenith—a cyclic olefin polymer available in the form of vials, syringes, and cartridges—and self-injection devices are also provided. The segment integrates various solutions, including analytical lab services, pre-approval primary packaging support, regulatory expertise, and after-sales technical support to serve biologics, generics, and pharmaceutical drug companies. The Contract-Manufactured Products segment focuses on designing, manufacturing, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products, servicing pharmaceutical, diagnostic, and medical device companies. The weighted average number of diluted shares outstanding is 72,700,000.00 reflecting potential dilution effects. The net total of other income and expenses is -$2,100,000.00 reflecting non-core financial activities. The company's stock is identified with the symbol 'WST' in the market. The earnings per share (EPS) is reported at $6.83 indicating the company's profitability on a per-share basis. Additionally, the weighted average number of shares outstanding is 72,300,000.00 highlighting the company's shareholder base. The stock is priced at $254.85 positioning it in the higher-end market. With an average trading volume of 942,801.00 the stock indicates moderate liquidity. The company has a mid-range market capitalization of $17,308,927,095.00 marking it as a steady performer. It is a key player in the Medical - Instruments & Supplies industry, contributing significantly to the overall market landscape. Furthermore, it belongs to the Healthcare sector, driving innovation and growth.